查看文章

PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol. 2017; 8: 561

作者

Hashem O Alsaab, Samaresh Sau, Rami Alzhrani, Katyayani Tatiparti, Ketki Bhise, Sushil K Kashaw, Arun K Iyer

发表日期

2017

期刊

Frontiers Media SA DOI

卷号

10

引用总数

被引用次数：75

201720182019202020212022202320242 1 13 11 12 11 16 9

学术搜索中的文章

PD-1 and PD-L1 checkpoint signaling inhibition for cancer immunotherapy: mechanism, combinations, and clinical outcome. Front Pharmacol. 2017; 8: 561

HO Alsaab, S Sau, R Alzhrani, K Tatiparti, K Bhise… - Frontiers Media SA DOI, 2017

被引用次数：75 相关文章